Commercialization Reports. Throughout the Term and during the Post- termination Period, and within thirty (30) days of the date specified in the schedule set forth in section 10 of the EPLA, the Licensee shall deliver to the University written reports of the Licensee’s and sublicensees’ (or any further sublicensees’) efforts and plans to commercialize the Licensed Technology and to manufacture, offer to sell, or sell Licensed Products.
Appears in 3 contracts
Samples: Exclusive Patent License Agreement, Exclusive Patent License Agreement (Calyxt, Inc.), Exclusive Patent License Agreement (Calyxt, Inc.)
Commercialization Reports. Throughout the Term and during the Post- Post-termination Period, and within thirty (30) days of the date specified in the schedule set forth in section 10 of the EPLA, the Licensee shall deliver to the University written reports of the Licensee’s and the sublicensees’ (or any further sublicensees’) efforts and plans to commercialize the Licensed Technology and to manufacture, offer to sell, or sell Licensed Products.
Appears in 3 contracts
Samples: Exclusive Patent License Agreement (Cellectis S.A.), Exclusive Patent License Agreement (GT Biopharma, Inc.), Exclusive Patent License Agreement (Cellectis S.A.)
Commercialization Reports. Throughout the Term and during the Post- Post-termination Period, and within thirty (30) days of the date specified in the schedule set forth in section 10 of the EPLA, the Licensee shall deliver to the University written reports of the Licensee’s and its sublicensees’ (or any further sublicensees’) efforts and plans to commercialize the Licensed Technology and to manufacture, offer to sell, or sell Licensed Products.
Appears in 1 contract
Samples: Confidentiality Agreement (Miromatrix Medical Inc.)
Commercialization Reports. Throughout the Term and during the Post- Post-termination Period, and within thirty (30) days of the date specified in the schedule set forth in section 10 of the EPLA, the Licensee shall deliver to the University written reports of the Licensee’s and sublicenseesthe Sublicensees’ (or any further sublicensees’) efforts and plans to commercialize the Licensed Technology and to manufacture, offer to sell, or sell Licensed Products. INFORMATION MARKED BY [***] HAS BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED PORTION HAS BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION.
Appears in 1 contract
Samples: Exclusive Patent License Agreement (Arno Therapeutics, Inc)
Commercialization Reports. Throughout the Term and during the Post- Post-termination Period, and within thirty (30) days of the date specified in the schedule set forth in section 10 of the EPLA, the Licensee shall deliver to the University written reports of the Licensee’s 's and the sublicensees’ (or any further sublicensees’) ' efforts and plans to commercialize the Licensed Technology and to manufacture, offer to sell, or sell Licensed Products.
Appears in 1 contract
Commercialization Reports. Throughout the Term and during the Post- Post termination Period, and within thirty (30) days of the date specified in the schedule set forth in section 10 of the EPLA, the Licensee shall deliver to the University written reports of the Licensee’s and the sublicensees’ (or any further sublicensees’) efforts and plans to commercialize the Licensed Technology and to manufacture, offer to sell, or sell Licensed Products.
Appears in 1 contract
Samples: Exclusive Patent License Agreement